- Resources
- …
- Resources
- Resources
- …
- Resources
Our Company
Allegrow Biotech started in March 2022, and we are now a proud incubatee of the IncuBio Program at the Hong Kong Science and Technology Parks.
Our vision is to decode complex cell surface signalling pathways to develop the next generation of cell therapy products that combine quality and cost-effectiveness.
We bring together bioengineering, cell biology and data science expertise to deliver immunomodulation solutions for both research and clinical applications.
Our Journey so far
20 de marzo de 2026Read more...We are pleased to announce that Allegrow Biotech has been selected for Precision Medicine P4...5 de enero de 2026Read more...We are excited to announce our partnership with Stratech Scientific, making Allegrow Biotech...21 de julio de 2025Read more...We are honored to have been awarded 3rd place at the EQT Impact Challenge Hong Kong 2025,...18 de marzo de 2025Read more...Allegrow Biotech Limited (煥境生物科技有限公司) has been awarded 𝐭𝐡𝐞 𝟑𝐫𝐝 𝐇𝐊𝐒𝐏𝐀 𝟐𝟎𝟐𝟑-𝟐𝟎𝟐𝟒 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐏𝐢𝐨𝐧...31 de octubre de 2024Read more...We are pleased to announce that Allegrow Biotech has secured investment from HKUST E-Fund, our...5 de junio de 2024Read more...We are excited to share a key milestone for Allegrow Biotech, as we are selected for the Incubio...17 de noviembre de 2023Read more...We are exhilarated to share that Allegrow has emerged triumphant as the Winner at Jumpstarter...Read more...Wonderful news! Allegrow was awarded with Gold Medal in 2023 48th Geneva International Exhibition...11 de abril de 2023Read more...We are thrilled to announce that Allegrow is one of the Technology Start-up Support Scheme for...Read all of our updates
Powered By
